TrialThe lancet. HIV2025

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial.

Lisa M Noguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.